Results 161 to 170 of about 37,262 (190)

Epigenetic regulation of PANoptosis: DNA methylation, histone modifications and non-coding RNAs. [PDF]

EXCLI J
Singh Y, Afzal M, Babu MA, Pandey SN, Rekha A, Gupta G, Kazmi I, Alzarea SI, Alsaidan OA, Almalki WH, Almujri SS.   +10 more
europepmc   +1 more source

Deciphering the molecular mechanisms of BPTF interactions with nucleosomes via molecular simulations. [PDF]

Biophys J
Hebert R, Wereszczynski J.
europepmc   +1 more source

Decoding Epigenetic Switches: How Histone Acetylation/Deacetylation Regulates Mononuclear/Macrophage Fate in Bone Disorders. [PDF]

Int J Biol Sci
Xu L, Shen C, Liu X, Qin Y, Wu Z, Zhang Z, Sheng Q, Wang Q, Zhou F, Ge G, Geng D.   +10 more
europepmc   +1 more source

BET Inhibitor JQ1 Attenuates Atrial Fibrillation Through Modulation of Fibrosis, Calcium Homeostasis, and Mitochondrial Function in a Murine Model. [PDF]

Int J Mol Sci
Song Z, Murakoshi N, Xu D, Xi B, Murakata Y, Aonuma K, Tajiri K, Ishizu T.   +7 more
europepmc   +1 more source

Development of cell-active BRD4-D1 selective inhibitors to decode the role of BET proteins in LPS-mediated liver inflammation. [PDF]

Eur J Med Chem
Scholtz CR, Doskey LC, Kandanur SGS, Vail NR, Roderick ER, Peterson EJ, Hoell ZJ, Shi K, Aihara H, Kostallari E, Shah VH, Malhi H, Pomerantz WCK.   +12 more
europepmc   +1 more source

Acetylation reader BRD4-driven TXNIP transcription enhances NLRP3 inflammasome activation in PCOS. [PDF]

Cell Mol Life Sci
Weng Y, Zhang Y, Dong W, Zhu Z, Xiang Z, Yan G, Wang H, Wen Y, Liu M, Wang D, Wang Y.   +10 more
europepmc   +1 more source

BRD4-mediated transcriptional activation of PDLIM4 enhances p21 stability and chemosensitivity in lung adenocarcinoma independent of p53. [PDF]

BMC Biol
Wang Q, Guo L, Wang S, Guan C, Pan J, Zhu S, Zheng L, Wu X, Gu Y, Shu T, Luo L, Lai T, Gao X.   +12 more
europepmc   +1 more source

Chromatin remodeling complexes: architects influencing breast cancer progression. [PDF]

Front Cell Dev Biol
Giovani O, Eckersley GS, Jones HR, Nagarajan S.   +3 more
europepmc   +1 more source

Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach. [PDF]

PLoS One
Leigh RS, Kaynak BL, Ruskoaho H, Välimäki MJ.   +3 more
europepmc   +1 more source